Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quest Diagnostics Inc (NYSE:DGX)

Delayed Data
As of 4:02pm ET
 -0.30 / -0.28%
Today’s Change
Today|||52-Week Range
Health Services
Services to the Health Industry

Company Description

Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions. The company operates through two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services segment comprised of two parts develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, ACOs, IDNs, employers and others. It provides diagnostic information services, which includes clinical testing services such as routine testing, gene-based and esoteric testing, anatomic pathology services, as well as related services and insights. The Diagnostic Solutions includes other businesses such as risk assessment services, clinical trials testing, diagnostic products and healthcare information technology. Quest Diagnostics was founded on December 31, 1996 and is headquartered in Madison, NJ.

Contact Information

Quest Diagnostics, Inc.
3 Giralda Farms
Madison New Jersey 07940
P:(800) 222-0446
Investor Relations:



Mutual fund holders50.17%
Other institutional41.54%
Individual stakeholders27.96%

Top Executives

Stephen H. RusckowskiChairman, President & Chief Executive Officer
Mark J. GuinanChief Financial Officer & Senior Vice President
Jay G. WohlgemuthChief Medical Officer, SVP-Research & Development
Lidia L. FonsecaChief Information Officer & Senior Vice President
Timothy U. SharpeVice President-Compliance